What is Allogene Therapeutics's income tax?

Allogene Therapeutics (ALLO) reported income tax of $0 in Q4 2025.

How has Allogene Therapeutics's income tax changed year-over-year?

Allogene Therapeutics's income tax decreased by 100.0% year-over-year, from $110.75K to $0.

What does income tax mean?

Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.

Allogene Therapeutics ALLO Income Tax

Discontinued — last reported Q4 '25

Income Tax at other companies

Bristol-Myers SquibbBMY

$561M+10.2%

Gilead SciencesGILD

$559M+67.4%

PrecigenPGEN

$0—

CRISPR TherapeuticsCRSP

$839K-24.3%

CytomX TherapeuticsCTMX

$59K-4.8%

Immix Biopharma, Inc.IMMX

$11.27K+4.5%

Segments

By segment

See full

Reportable Segment$0-100%

Other financials

Income statement

See full

Revenue-—

Operating income-$46.1M+29.3%

Net income-$42.6M+28.7%

EPS (diluted)-$0.18+35.7%

Balance sheet

See full

Cash & equivalents$40.6M-23.0%

Total debt$81.1M-8.9%

Total equity$278.9M-27.6%

Total assets$396.0M-22.1%

Cash flow

See full

Operating cash flow-$12.9M+75.6%

CapEx$9.0K-90.9%

Free cash flow-$12.9M+75.6%

Valuation

See full

Market cap$711.02M+164%

Enterprise value$751.47M+146%

Profitability

See full

Operating margin-1,241,813.6%-2,018,140pp

Net margin-1,170,863.6%-2,007,890pp

FCF margin-913,609.1%-1,474,890pp

Returns & leverage

See full

Return on equity-52.3%-5.7pp

Debt / equity0.3×+0.1×

Current ratio9.6×-0.1×

Where this comes from

Reported directly by Allogene Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: Allogene Therapeutics’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Allogene Therapeutics's income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Allogene Therapeutics's income tax?: Allogene Therapeutics (ALLO) reported income tax of $0 in Q4 2025.
How has Allogene Therapeutics's income tax changed year-over-year?: Allogene Therapeutics's income tax decreased by 100.0% year-over-year, from $110.75K to $0.
What does income tax mean?: Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.